Liver Cancer Diagnostics Global Market Report 2025

Global Liver Cancer Diagnostics Market Report 2024

Liver Cancer Diagnostics Global Market Report 2025 – By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By End Use (Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

Name: Liver Cancer Diagnostics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Liver Cancer Diagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Liver Cancer Diagnostics Global Market Report 2025

Proud Members Of

Liver Cancer Diagnostics Market Definition

Liver cancer diagnostics refers to the various methods employed to detect and diagnose liver cancer, a type of cancer that originates in the liver. It is used for the early detection and diagnosis of liver cancer via Imaging and molecular testing.

The main types of cancer included in liver cancer diagnostics are hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and others. Hepatocellular carcinoma (HCC) refers to the primary liver cancer that most commonly affects people who have cirrhosis and preexisting chronic liver disease. The several types of screening are involved are laboratory testing, imaging, endoscopy, biopsy, and others. The various types of technology are included, such as fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), and others, which are used in several end uses, such as hospitals and diagnostic laboratories, academic and research institutes, and pharmaceutical and CRO laboratories.

Liver Cancer Diagnostics Market Segmentation

The liver cancer diagnostics market covered in this report is segmented –

1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types

2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings

3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies

4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories

Subsegments:

1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma

2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma

3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma

4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma

Liver Cancer Diagnostics Market Size and growth rate 2025 to 2029: Graph

Liver Cancer Diagnostics Market Size 2025 And Growth Rate

The liver cancer diagnostics market size has grown strongly in recent years. It will grow from$9.69 billion in 2024 to $10.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to biopsy techniques and histopathology, development of biomarker detection, evolution of screening programs, advances in genetic testing, improvements in liver imaging modalities

Liver Cancer Diagnostics Market Growth Forecast

The liver cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to regulatory changes and standardization, growing importance of imaging modalities, development of next-generation sequencing, expanded screening programs and awareness, rising demand for biomarker-based testing. Major trends in the forecast period include rise in incidence and prevalence, advancements in imaging technologies, focus on non-invasive diagnostics, precision medicine and personalized diagnostics, integration of artificial intelligence (AI).

Book your 30 minutes free consultation with our research experts

Liver Cancer Diagnostics Market Driver: Rising Liver Cancer Prevalence Fuels Growth In Liver Cancer Diagnostics Market

The rising prevalence of liver cancer is expected to propel the growth of the liver cancer diagnostics market going forward. Liver cancer refers to the condition in which the liver cells grow and multiply out of control, giving rise to a life-threatening illness. Liver cancer diagnostic tests are performed to determine whether cancer cells are spreading within the liver or surrounding it after the diagnosis of primary carcinoma of the liver, so the rising prevalence of liver cancer boosts the liver cancer diagnostics market. For instance, in January 2023, according to the Cancer Facts & Figures 2023 report published by the American Cancer Society, a US-based voluntary health organization, the number of new cases of liver and intrahepatic bile duct cancer in females reached 13,230 in 2023, an increase from 12,640 in 2020, in the United States. Furthermore, in 2023, an estimated 41,210 new cases of liver cancer will be diagnosed in the US, where 29,380 people are expected to die. Therefore, the rising prevalence of liver cancer is driving the growth of the liver cancer diagnostic market.

Liver Cancer Diagnostics Market Driver: Elevated Hepatitis B Incidence Fuels Surge In Demand For Advanced Liver Cancer Diagnostics

Growing prevalence of hepatitis B is expected to propel the growth of the liver cancer diagnostics market. Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic diseases. Individuals with chronic hepatitis B are advised to undergo regular monitoring to assess the health of their liver and detect any signs of liver damage or cancer. For instance, in July 2022, according to Centres for Disease Control and Prevention, a US-based national public health agency, Hepatitis B affects approximately 296 million people, including over 6 million children under the age of 5. Therefore, growing prevalence of hepatitis B is driving the growth of the liver cancer diagnostics market

Global Liver Cancer Diagnostics Market Major Players

Major companies operating in the liver cancer diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen NV, Thermo Fisher Scientific Inc., Siemens Healthineers, Illumina Inc., Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc., Danaher Corporation, Foundation Medicine Inc., Agilent Technologies Inc., Genemed Biotechnologies Inc., Merck KGaA, Fujifilm Medical Systems USA Inc., GE Healthcare, Advanced Cell Diagnostics Inc., Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon A/S, BioGenex Laboratories Inc., OncoCyte Corporation, Guardant Health Inc., Exact Sciences Corporation, Grail Inc., Freenome Holdings Inc., Natera Inc., Personal Genome Diagnostics Inc., Thrive Earlier Detection Corp

Global Liver Cancer Diagnostics Market Trend: Advanced Biomarker-Based Assays Launched To Improve Liver Cancer Diagnostics

Major companies operating in the liver cancer diagnostics market are developing advanced biomarker-based assays and algorithms to improve diagnostic accuracy and support early detection. Biomarker-based assays and algorithms refer to diagnostic tools that utilize specific biological markers to identify diseases, providing more precise and efficient diagnostic capabilities. For instance, in November 2023, Roche Diagnostics, a US-based biotech corporation, launched the Elecsys PIVKA-II assay and Elecsys GAAD algorithm. The Elecsys PIVKA-II assay detects elevated levels of the PIVKA-II biomarker, which is associated with hepatocellular carcinoma (HCC), improving early detection of liver cancer in high-risk patients. The Elecsys GAAD algorithm integrates multiple diagnostic markers, such as PIVKA-II and AFP, to enhance diagnostic precision and streamline decision-making in liver cancer detection.

Liver Cancer Diagnostics Market Merger And Acquisition: Integrated DNA Technologies Expands NGS Portfolio With Strategic Acquisition

In April 2023, Integrated DNA Technologies, a US-based biotechnology company acquired Archer NGS research assays for an undisclosed amount. Through this acquisition, Integrated DNA Technologies aimed to enhance its portfolio in next-generation sequencing (NGS), focusing on expanding its research capabilities and improving assay development for genomic research. Archer, Inc. is a US-based provider of liver cancer diagnostic solutions.

Liver Cancer Diagnostics Market Merger And Acquisition: Fujifilm Expands Healthcare Portfolio With Acquisition Of Inspirata

In December 2022, Fujifilm Holdings Corporation, a Japan-based conglomerate engaged in healthcare and biotech product development acquired Inspirata for an undisclosed amount. With this acquisition, Fujifilm will take over Dynamyx digital pathology technology, and staff and clients of Inspirata joined Fujifilm. The inclusion of digital pathology would broaden Fujifilm's strong Synapse Enterprise Imaging portfolio, enabling the incorporation of pathology data and images into a company's electronic medical record system and aiding in the streamlining of treatment for cancer patients and care teams. Inspirata is a US-based company engaged in providing oncology informatics and healthcare IT solutions.

Regional Analysis For The Global Liver Cancer Diagnostics Market

North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the liver cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Liver Cancer Diagnostics Market?

The liver cancer diagnostics market includes revenues earned by entities by liver transplants, CT scans, and liver function tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cancer diagnostics market also includes sales of In Vitro and Imaging Tools, AI tools, and ML tools which are used in providing liver cancer diagnostic services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Liver Cancer Diagnostics Industry?

The liver cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver cancer diagnostics market statistics, including liver cancer diagnostics industry global market size, regional shares, competitors with a liver cancer diagnostics market share, detailed liver cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver cancer diagnostics industry. This liver cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Liver Cancer Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$10.4 billion
Revenue Forecast In 2034	$13.86 billion
Growth Rate	CAGR of 7.4% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types 2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings 3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies 4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories Subsegments: 1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma 2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma 3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma 4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen NV, Thermo Fisher Scientific Inc., Siemens Healthineers, Illumina Inc., Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc., Danaher Corporation, Foundation Medicine Inc., Agilent Technologies Inc., Genemed Biotechnologies Inc., Merck KGaA, Fujifilm Medical Systems USA Inc., GE Healthcare, Advanced Cell Diagnostics Inc., Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon A/S, BioGenex Laboratories Inc., OncoCyte Corporation, Guardant Health Inc., Exact Sciences Corporation, Grail Inc., Freenome Holdings Inc., Natera Inc., Personal Genome Diagnostics Inc., Thrive Earlier Detection Corp
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Liver Cancer Diagnostics Market Characteristics

3. Liver Cancer Diagnostics Market Trends And Strategies

4. Liver Cancer Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Liver Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Liver Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Liver Cancer Diagnostics Market Growth Rate Analysis

5.4. Global Liver Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Liver Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Liver Cancer Diagnostics Total Addressable Market (TAM)

6. Liver Cancer Diagnostics Market Segmentation

6.1. Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hepatocellular Carcinoma

Cholangiocarcinoma

Hepatoblastoma

Other Types

6.2. Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laboratory Testing

Imaging

Endoscopy

Biopsy

Other Screenings

6.3. Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fluorescent In Situ Hybridization (FISH)

Comparative Genomic Hybridization (CGH)

Immunohistochemical (IHC)

Other Technologies

6.4. Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Diagnostic Laboratories

Academic And Research Institutes

Pharmaceutical And CRO Laboratories

6.5. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early-Stage Hepatocellular Carcinoma

Advanced-Stage Hepatocellular Carcinoma

6.6. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intrahepatic Cholangiocarcinoma

Extrahepatic Cholangiocarcinoma

6.7. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pure Hepatoblastoma

Mixed Hepatoblastoma

6.8. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Secondary Liver Cancer

Fibrolamellar Carcinoma

7. Liver Cancer Diagnostics Market Regional And Country Analysis

7.1. Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Cancer Diagnostics Market

8.1. Asia-Pacific Liver Cancer Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Cancer Diagnostics Market

9.1. China Liver Cancer Diagnostics Market Overview

9.2. China Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Cancer Diagnostics Market

10.1. India Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Cancer Diagnostics Market

11.1. Japan Liver Cancer Diagnostics Market Overview

11.2. Japan Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Cancer Diagnostics Market

12.1. Australia Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Cancer Diagnostics Market

13.1. Indonesia Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Cancer Diagnostics Market

14.1. South Korea Liver Cancer Diagnostics Market Overview

14.2. South Korea Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Cancer Diagnostics Market

15.1. Western Europe Liver Cancer Diagnostics Market Overview

15.2. Western Europe Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Cancer Diagnostics Market

16.1. UK Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Cancer Diagnostics Market

17.1. Germany Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Cancer Diagnostics Market

18.1. France Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Cancer Diagnostics Market

19.1. Italy Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Cancer Diagnostics Market

20.1. Spain Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Cancer Diagnostics Market

21.1. Eastern Europe Liver Cancer Diagnostics Market Overview

21.2. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Cancer Diagnostics Market

22.1. Russia Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Cancer Diagnostics Market

23.1. North America Liver Cancer Diagnostics Market Overview

23.2. North America Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Cancer Diagnostics Market

24.1. USA Liver Cancer Diagnostics Market Overview

24.2. USA Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Cancer Diagnostics Market

25.1. Canada Liver Cancer Diagnostics Market Overview

25.2. Canada Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Cancer Diagnostics Market

26.1. South America Liver Cancer Diagnostics Market Overview

26.2. South America Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Cancer Diagnostics Market

27.1. Brazil Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Cancer Diagnostics Market

28.1. Middle East Liver Cancer Diagnostics Market Overview

28.2. Middle East Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Cancer Diagnostics Market

29.1. Africa Liver Cancer Diagnostics Market Overview

29.2. Africa Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Cancer Diagnostics Market Competitive Landscape And Company Profiles

30.1. Liver Cancer Diagnostics Market Competitive Landscape

30.2. Liver Cancer Diagnostics Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Liver Cancer Diagnostics Market Other Major And Innovative Companies

31.1. Illumina Inc.

31.2. Koninklijke Philips NV

31.3. Epigenomics AG

31.4. Digna Biotech SL

31.5. Biocept Inc.

31.6. Danaher Corporation

31.7. Foundation Medicine Inc.

31.8. Agilent Technologies Inc.

31.9. Genemed Biotechnologies Inc.

31.10. Merck KGaA

31.11. Fujifilm Medical Systems USA Inc.

31.12. GE Healthcare

31.13. Advanced Cell Diagnostics Inc.

31.14. Oxford Gene Technology

31.15. Leica Biosystems Nussloch GmbH

32. Global Liver Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Cancer Diagnostics Market

34. Recent Developments In The Liver Cancer Diagnostics Market

35. Liver Cancer Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Liver Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Liver Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Liver Cancer Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Abbott Laboratories Financial Performance

Table 80: F. Hoffmann-La Roche Ltd. Financial Performance

Table 81: Qiagen NV Financial Performance

Table 82: Thermo Fisher Scientific Inc. Financial Performance

Table 83: Siemens Healthineers Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Abbott Laboratories Financial Performance

Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 81: Qiagen NV Financial Performance

Figure 82: Thermo Fisher Scientific Inc. Financial Performance

Figure 83: Siemens Healthineers Financial Performance

Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

How Will The Laryngoscope Market Grow In 2022?

The Business Research Company offers the single use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the temperature monitoring devices market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the urinary incontinence and pelvic organ prolapse devices and equipment market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dental equipment and supplies market research report 2022 with industry size, share, segments and market growth

Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Transplant Diagnostics Global Market Report 2025 – By Type (Reagent & Consumables, Instrument, Software & Services), By Transplant Type (Solid Organ, Stem Cell), By Organ (Kidney, Liver, Heart, Lung, Pancreas), By Technology (Non Molecular Assay, Molecular Assay), By End User (Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Precision Medicine Global Market Report 2025 – By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology), By Application (Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.), By End-Use (Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Transfusion Diagnostics Global Market Report 2025 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cervical Cancer Diagnostics Global Market Report 2025 – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests), By Age Group (Below 21, Age between 21 to 29, Age between 30 to 65, Above 65), By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centers, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Liver Cancer Diagnostics market?

How will the Liver Cancer Diagnostics market drivers and restraints affect the market dynamics? What forces will shape the Liver Cancer Diagnostics industry going forward?

The Liver Cancer Diagnostics market major growth driver - Rising Liver Cancer Prevalence Fuels Growth In Liver Cancer Diagnostics Market. For further insights on the Liver Cancer Diagnostics market, request a sample here

What is the forecast market size or the forecast market value of the Liver Cancer Diagnostics market?

The Liver Cancer Diagnostics market size has grown strongly in recent years. The liver cancer diagnostics market size has grown strongly in recent years. It will grow from$9.69 billion in 2024 to $10.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to biopsy techniques and histopathology, development of biomarker detection, evolution of screening programs, advances in genetic testing, improvements in liver imaging modalities The liver cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to regulatory changes and standardization, growing importance of imaging modalities, development of next-generation sequencing, expanded screening programs and awareness, rising demand for biomarker-based testing. Major trends in the forecast period include rise in incidence and prevalence, advancements in imaging technologies, focus on non-invasive diagnostics, precision medicine and personalized diagnostics, integration of artificial intelligence (AI). For further insights on the Liver Cancer Diagnostics market, request a sample here

How is the Liver Cancer Diagnostics market segmented?

The liver cancer diagnostics market covered in this report is segmented –
1) By Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types
2) By Screening: Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories Subsegments:
1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma, Advanced-Stage Hepatocellular Carcinoma
2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma
3) By Hepatoblastoma: Pure Hepatoblastoma, Mixed Hepatoblastoma
4) Other Types: Secondary Liver Cancer, Fibrolamellar Carcinoma For further insights on the Liver Cancer Diagnostics market, request a sample here

Which region has the largest share of the Liver Cancer Diagnostics market? What are the other regions covered in the report?

North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Liver Cancer Diagnostics market, request a sample here.

Who are the major players in the Liver Cancer Diagnostics market?

What are the key trends in the Liver Cancer Diagnostics market?

Major trends in the Liver Cancer Diagnostics market include Advanced Biomarker-Based Assays Launched To Improve Liver Cancer Diagnostics. For further insights on the Liver Cancer Diagnostics market, request a sample here.

What are the major opportunities in the Liver Cancer Diagnostics market? What are the strategies for the Liver Cancer Diagnostics market?

For detailed insights on the major opportunities and strategies in the Liver Cancer Diagnostics market, request a sample here.

How does the Liver Cancer Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Liver Cancer Diagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Liver Cancer Diagnostics industry?

For detailed insights on the mergers and acquisitions in the Liver Cancer Diagnostics industry, request a sample here.

What are the key dynamics influencing the Liver Cancer Diagnostics market growth? SWOT analysis of the Liver Cancer Diagnostics market.

For detailed insights on the key dynamics influencing the Liver Cancer Diagnostics market growth and SWOT analysis of the Liver Cancer Diagnostics industry, request a sample here.